Immunological considerations for COVID-19 vaccine strategies
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …
Coronavirus vaccine development: from SARS and MERS to COVID-19
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of
coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the …
coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the …
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
More than 190 vaccines are currently in development to prevent infection by the novel
severe acute respiratory syndrome coronavirus 2. Animal studies suggest that while …
severe acute respiratory syndrome coronavirus 2. Animal studies suggest that while …
[HTML][HTML] mRNA vaccines for COVID-19: what, why and how
Abstract The Coronavirus disease-19 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), has impacted human lives in the most …
respiratory syndrome coronavirus-2 (SARS-CoV-2), has impacted human lives in the most …
Lessons for COVID-19 immunity from other coronavirus infections
A Sariol, S Perlman - Immunity, 2020 - cell.com
A key goal to controlling coronavirus disease 2019 (COVID-19) is develo** an effective
vaccine. Development of a vaccine requires knowledge of what constitutes a protective …
vaccine. Development of a vaccine requires knowledge of what constitutes a protective …
Prospects for a safe COVID-19 vaccine
BF Haynes, L Corey, P Fernandes, PB Gilbert… - Science translational …, 2020 - science.org
Rapid development of an efficacious vaccine against the viral pathogen severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of the coronavirus disease …
respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of the coronavirus disease …
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
As SARS-CoV-2 vaccines are deployed worldwide, a comparative evaluation is important to
underpin decision-making. We here report a systematic literature review and meta-analysis …
underpin decision-making. We here report a systematic literature review and meta-analysis …
COVID-19: coronavirus vaccine development updates
J Zhao, S Zhao, J Ou, J Zhang, W Lan, W Guan… - Frontiers in …, 2020 - frontiersin.org
Coronavirus Disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), a newly emerged coronavirus, and has been pandemic since …
Coronavirus 2 (SARS-CoV-2), a newly emerged coronavirus, and has been pandemic since …
Vaccines for COVID-19: The current state of play
A Koirala, YJ Joo, A Khatami, C Chiu… - Paediatric respiratory …, 2020 - Elsevier
There is a strong consensus globally that a COVID-19 vaccine is likely the most effective
approach to sustainably controlling the COVID-19 pandemic. An unprecedented research …
approach to sustainably controlling the COVID-19 pandemic. An unprecedented research …
Learning from the past: development of safe and effective COVID-19 vaccines
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
elicited an equally rapid response aiming to develop a COVID-19 vaccine. These efforts are …
elicited an equally rapid response aiming to develop a COVID-19 vaccine. These efforts are …